These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 3546012)

  • 1. [Does insulin resistance present a significant problem in type 2 diabetes?].
    Glaser B; Leibovitch G; Nesher R; Cerasi E
    Harefuah; 1986 Nov; 111(10):330-3. PubMed ID: 3546012
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of impaired insulin secretion and insulin resistance in the pathogenesis of type 2 diabetes mellitus.
    Szoke E; Gerich JE
    Compr Ther; 2005; 31(2):106-12. PubMed ID: 15901939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of ponderal on the state of carbohydrate metabolism and insulin secretion in type 2 diabetes mellitus].
    Balabolkin MI; Novikova OM; Levitskaia ZI
    Sov Med; 1991; (11):56-9. PubMed ID: 1767320
    [No Abstract]   [Full Text] [Related]  

  • 4. [From obesity to diabetes or the natural history of abnormalities in the secretion and action of insulin].
    Scheen AJ
    Rev Med Liege; 1992 Jul; 47(7):325-37. PubMed ID: 1636074
    [No Abstract]   [Full Text] [Related]  

  • 5. Insulin resistance is not necessarily an essential component of type 2 diabetes.
    Gerich JE
    J Clin Endocrinol Metab; 2000 Jun; 85(6):2113-5. PubMed ID: 10852436
    [No Abstract]   [Full Text] [Related]  

  • 6. The biological role of islet amyloid polypeptide (amylin) in diabetes: some recent results.
    Sandler S
    Diabetologia; 1994 Feb; 37(2):225-6. PubMed ID: 8163061
    [No Abstract]   [Full Text] [Related]  

  • 7. New pharmacologic approaches to the treatment of diabetes.
    Johnson DG; Bressler R
    Spec Top Endocrinol Metab; 1984; 6():163-92. PubMed ID: 6151747
    [No Abstract]   [Full Text] [Related]  

  • 8. [Provisional intensive insulin therapy in non-insulin-dependent diabetes resistant to usual treatment].
    Bringer J; Galtier-Dereure F; Augustin-Pascalis I; Richard JL; Parer-Richard C; Mirouze J; Jaffiol C
    Journ Annu Diabetol Hotel Dieu; 1993; ():115-22. PubMed ID: 8331859
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of insulin treatment on insulin secretion and insulin resistance in obese type II diabetics].
    Hidaka H
    Horumon To Rinsho; 1982 Jul; 30(7):699-704. PubMed ID: 6751623
    [No Abstract]   [Full Text] [Related]  

  • 10. Therapeutic approach in insulin resistance with acanthosis nigricans.
    Tankova T; Koev D; Dakovska L; Kirilov G
    Int J Clin Pract; 2002 Oct; 56(8):578-81. PubMed ID: 12425366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From obesity to diabetes. Pathophysiological considerations.
    Felber JP
    Int J Obes Relat Metab Disord; 1992 Dec; 16(12):937-52. PubMed ID: 1335973
    [No Abstract]   [Full Text] [Related]  

  • 12. [Role of insulin receptors in the pathogenesis and treatment of diabetes].
    Lenti G; Pagano G; Cassader M
    Journ Annu Diabetol Hotel Dieu; 1978; ():73-86. PubMed ID: 349230
    [No Abstract]   [Full Text] [Related]  

  • 13. [Etiopathogenesis, physiopathology and general principles of therapy of type II diabetes].
    Scheen A; Lefèbvre PJ
    Rev Med Liege; 1988 Apr; 43(7):205-11. PubMed ID: 3287543
    [No Abstract]   [Full Text] [Related]  

  • 14. Pathogenesis of type 2 diabetes mellitus.
    DeFronzo RA
    Med Clin North Am; 2004 Jul; 88(4):787-835, ix. PubMed ID: 15308380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin analog lispro decreases insulin resistance and improves glycemic control in an obese patient with insulin-requiring type 2 diabetes.
    Darmon P; Curtillet C; Boullu S; Laugier A; Dutour A; Oliver C
    Diabetes Care; 1998 Sep; 21(9):1575. PubMed ID: 9727917
    [No Abstract]   [Full Text] [Related]  

  • 16. [Insulin secretion in the clinical stages of diabetes (with glucose tolerance test abnormalities)].
    Vague P; Vague J
    Journ Annu Diabetol Hotel Dieu; 1972; 13(0):55-65. PubMed ID: 4605752
    [No Abstract]   [Full Text] [Related]  

  • 17. Glucose metabolism in obesity and type 2 diabetes.
    Bonadonna RC; De Fronzo RA
    Diabete Metab; 1991 May; 17(1 Pt 2):112-35. PubMed ID: 1936466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The natural history of diabetes with respect to disorders of insulin function].
    Dorner M; Pinget M; Brogard JM; Sapin R; Paris-Bockel D; Levy P; Jung C
    Journ Annu Diabetol Hotel Dieu; 1984; ():51-71. PubMed ID: 6399540
    [No Abstract]   [Full Text] [Related]  

  • 19. Improvement of insulin secretion but not insulin resistance after short term control of plasma glucose in obese type II diabetics.
    Hidaka H; Nagulesparan M; Klimes I; Clark R; Sasaki H; Aronoff SL; Vasquez B; Rubenstein AH; Unger RH
    J Clin Endocrinol Metab; 1982 Feb; 54(2):217-22. PubMed ID: 7033272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tumor necrosis factor-alpha; a possible pathogenic factor in obesity in insulin resistant and non-insulin-dependent diabetes mellitus?].
    Winkler G; Salamon F; Simon K; Cseh K
    Orv Hetil; 1998 Jul; 139(27):1627-32. PubMed ID: 9685802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.